北美抗体发现市场预测至 2030 年 - 区域分析 - 按抗体类型（单克隆抗体、多克隆抗体及其他）、性质（人类和人源化、嵌合和鼠类）、服务（噬菌体展示、杂交瘤、转基因动物、单细胞和酵母展示）和最终用户（制药和生物技术公司、研究实验室及其他）
增加研发投资推动北美抗体发现市场
抗体（包括单克隆抗体和多克隆抗体）可应用于学术、研究和制药机构和组织，其中它们用于与药物和生物标志物开发以及其他治疗和临床诊断产品开发相关的多项研发活动。中小型公司每年都专注于增加研发投资。 2020 年 4 月，美国联邦政府根据《冠状病毒援助、救济和经济安全 (CARES) 法案》向生物医学高级研究与发展局 (BARDA) 拨款 35 亿美元，为疫苗、诊断、治疗和小分子活性药物成分 (API) 等的制造、生产和采购提供资金支持。此外，制药公司 Bio-Rad 提供 10,000 种抗体以及抗原、试剂和缓冲液，用于开发体外诊断测试。因此，制药公司在与抗体发现相关的研发活动方面的投资不断增加，以开发针对各种疾病的更好治疗方案，推动了抗体发现市场的增长。
北美抗体发现市场概览
北美抗体发现市场分为美国、加拿大和墨西哥。该地区的市场增长取决于癌症患病率的增加、抗体研究行业的强大存在以及研发领域的技术进步。根据美国癌症协会的数据，2020 年美国诊断出约 180 万例新癌症病例，约 606,520 例癌症相关死亡病例。这增加了对治疗性抗体的需求，从而推动了抗体发现市场的增长。资金的激增进一步推动了新技术的开发、跨国家和组织汇集资源和专业知识以及对现有抗体治疗方法进行研究。这使人们更好地了解了免疫系统，并开发了有效和有针对性的抗体。此外，增加的资金使科学家能够进行大规模临床试验，这些试验对于评估特定抗体的有效性是必不可少的。
北美抗体发现市场收入和预测到 2030 年（十亿美元）
北美抗体发现市场细分
北美抗体发现市场分为抗体类型、性质、服务、最终用户和国家。
根据抗体类型，北美抗体发现市场细分为单克隆抗体、多克隆抗体和其他。单克隆抗体部分在 2022 年占据了北美抗体发现市场的最大份额。
就性质而言，北美抗体发现市场细分为人类和人源化、嵌合和鼠类。人类和人源化部分在 2022 年占据了北美抗体发现市场的最大份额。
按服务，北美抗体发现市场分为噬菌体展示、杂交瘤、转基因动物、单细胞和酵母展示。噬菌体展示部分在 2022 年占据了北美抗体发现市场的最大份额。
根据最终用户，北美抗体发现市场分为制药和生物技术公司、研究实验室等。 2022 年，制药和生物技术公司部门占据了北美抗体发现市场的最大份额。
根据国家/地区，北美抗体发现市场分为美国、加拿大和墨西哥。2022 年，美国占据了北美抗体发现市场份额的主导地位。
Charles River Laboratories International Inc、Creative Biolabs Inc、Evotec SE、Bruker Cellular Analysis Inc、BioDuro LLC、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp、NanoCellect Biomedical Inc 和 Biocytogen Pharmaceuticals Beijing Co Ltd. 是北美抗体发现市场的一些领先公司。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Antibody Discovery Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Investments in Research & Development
4.1.2 Rising Incidence of Cancer
4.2 Market Restraints
4.2.1 High Cost of Production
4.3 Market Opportunities
4.3.1 Proliferation of Biotechnology Industry in Developing Regions
4.4 Future Trends
4.4.1 Developments for Custom Antibodies
4.5 Impact of Drivers and Restraints:
5. Antibody Discovery Market - North America Market Analysis
5.1 North America Antibody Discovery Market Revenue (US$ Million), 2020-2030
6. North America Antibody Discovery Market Analysis - by Antibody Type
6.1 Overview
6.2 Monoclonal Antibodies
6.2.1 Overview
6.2.2 Monoclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
6.3.1 Overview
6.3.2 Polyclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7. North America Antibody Discovery Market Analysis - by Nature
7.1 Overview
7.2 Human and Humanized
7.2.1 Overview
7.2.2 Human and Humanized: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
7.3.1 Overview
7.3.2 Chimeric: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
7.4.1 Overview
7.4.2 Murine: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Antibody Discovery Market Analysis - by Services
8.1 Overview
8.2 Phage Display
8.2.1 Overview
8.2.2 Phage Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
8.3.1 Overview
8.3.2 Hybridoma: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
8.4.1 Overview
8.4.2 Transgenic Animal: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
8.5.1 Overview
8.5.2 Yeast Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
8.6.1 Overview
8.6.2 Single Cell: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Antibody Discovery Market Analysis - by End User
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
9.3.1 Overview
9.3.2 Research Laboratories: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Antibody Discovery Market - Country Analysis
10.1 North America Market Overview
10.1.1 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
10.1.1.1 US
10.1.1.1.1 Overview
10.1.1.1.2 US: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 United States: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.4 United States: Antibody Discovery Market Breakdown, by Nature
10.1.1.1.5 United States: Antibody Discovery Market Breakdown, by Services
10.1.1.1.6 United States: Antibody Discovery Market Breakdown, by End User
10.1.1.2 Canada
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Canada: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.4 Canada: Antibody Discovery Market Breakdown, by Nature
10.1.1.2.5 Canada: Antibody Discovery Market Breakdown, by Services
10.1.1.2.6 Canada: Antibody Discovery Market Breakdown, by End User
10.1.1.3 Mexico
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Mexico: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.4 Mexico: Antibody Discovery Market Breakdown, by Nature
10.1.1.3.5 Mexico: Antibody Discovery Market Breakdown, by Services
10.1.1.3.6 Mexico: Antibody Discovery Market Breakdown, by End User
11. Antibody Discovery Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Creative Biolabs Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Evotec SE
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bruker Cellular Analysis Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BioDuro LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Sartorius AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Aragen Life Sciences Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Twist Bioscience Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NanoCellect Biomedical Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Biocytogen Pharmaceuticals Beijing Co Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. North America Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 4. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 5. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 6. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 7. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 8. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 9. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 10. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 11. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 12. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 13. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 14. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 16. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 17. Glossary of Terms, Antibody Discovery Market
List of Figures
Figure 1. North America Antibody Discovery Market Segmentation, by Country
Figure 2. North America Antibody Discovery Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
Figure 5. North America Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
Figure 6. Monoclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Polyclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
Figure 10. Human and Humanized: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chimeric: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Murine: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. North America Antibody Discovery Market Share (%) - by Services (2022 and 2030)
Figure 14. Phage Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hybridoma: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Transgenic Animal: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Yeast Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Single Cell: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. North America Antibody Discovery Market Share (%) - by End User (2022 and 2030)
Figure 20. Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Research Laboratories: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. North America: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. US: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 26. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 27. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Growth Strategies in the Antibody Discovery Market
- Charles River Laboratories International Inc
- Creative Biolabs Inc
- Evotec SE
- Bruker Cellular Analysis Inc
- BioDuro LLC
- Sartorius AG
- Aragen Life Sciences Ltd
- Twist Bioscience Corp
- NanoCellect Biomedical Inc
- Biocytogen Pharmaceuticals Beijing Co Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America antibody discovery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America antibody discovery market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.